CME Group Inc. $CME Shares Acquired by Sumitomo Life Insurance Co.

Sumitomo Life Insurance Co. lifted its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 13.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,438 shares of the financial services provider’s stock after buying an additional 6,137 shares during the quarter. Sumitomo Life Insurance Co.’s holdings in CME Group were worth $13,774,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Asset Dedication LLC lifted its stake in CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 37 shares during the last quarter. FNY Investment Advisers LLC bought a new position in CME Group during the fourth quarter worth $27,000. Hilton Head Capital Partners LLC bought a new position in CME Group during the fourth quarter worth $28,000. Global Wealth Strategies & Associates lifted its stake in CME Group by 1,250.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 108 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 100 shares during the last quarter. Finally, Legacy Wealth Managment LLC ID lifted its stake in CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the transaction, the general counsel owned 7,192 shares of the company’s stock, valued at approximately $2,397,597.04. This trade represents a 31.39% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Terrence A. Duffy sold 35,000 shares of CME Group stock in a transaction dated Friday, May 15th. The stock was sold at an average price of $298.51, for a total value of $10,447,850.00. Following the completion of the transaction, the chief executive officer directly owned 55,630 shares in the company, valued at $16,606,111.30. This represents a 38.62% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 44,044 shares of company stock valued at $13,297,507. 0.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CME shares. Deutsche Bank Aktiengesellschaft reduced their price objective on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. Jefferies Financial Group reduced their price objective on CME Group from $356.00 to $349.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. Weiss Ratings restated a “buy (a-)” rating on shares of CME Group in a research note on Friday, May 29th. JPMorgan Chase & Co. raised their price objective on CME Group from $266.00 to $271.00 and gave the stock an “underweight” rating in a research note on Thursday, April 16th. Finally, Barclays reduced their price objective on CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 23rd. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, CME Group has an average rating of “Moderate Buy” and an average target price of $305.71.

View Our Latest Research Report on CME

CME Group Price Performance

Shares of NASDAQ CME opened at $269.53 on Friday. CME Group Inc. has a fifty-two week low of $244.56 and a fifty-two week high of $329.16. The firm’s 50-day simple moving average is $284.79 and its 200 day simple moving average is $288.07. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $97.67 billion, a P/E ratio of 23.00, a P/E/G ratio of 2.93 and a beta of 0.21.

CME Group (NASDAQ:CMEGet Free Report) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The firm had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.CME Group’s revenue was up 14.5% compared to the same quarter last year. During the same period in the previous year, the company earned $2.80 earnings per share. Equities analysts expect that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 25th. Investors of record on Tuesday, June 9th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is presently 44.37%.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

CME Group Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.